Merck & Co IncNYSE:MRK
- LAST PRICE131.0900
- TODAY'S CHANGE (%)-0.0100 (-0.0076%)
- Bid / Lots131.2000/ 1
- Ask / Lots131.8200/ 1
- Open / Previous Close130.9000 / 131.1000
- Day Range
- 52 Week Range
- Volume6,830,937
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MRK |
|---|---|---|
| 09:32 ET | 116953 | 130.61 |
| 09:34 ET | 9313 | 130.48 |
| 09:36 ET | 22619 | 130.59 |
| 09:38 ET | 14009 | 130.8725 |
| 09:39 ET | 14846 | 130.92 |
| 09:41 ET | 28795 | 131 |
| 09:43 ET | 14773 | 131.16 |
| 09:45 ET | 11756 | 131.21 |
| 09:48 ET | 13684 | 131.19 |
| 09:50 ET | 14221 | 131.19 |
| 09:52 ET | 10537 | 131.135 |
| 09:54 ET | 10282 | 130.96 |
| 09:56 ET | 5657 | 131.04 |
| 09:57 ET | 8549 | 131.08 |
| 09:59 ET | 25857 | 131.21 |
| 10:01 ET | 21598 | 131.21 |
| 10:03 ET | 11311 | 131.25 |
| 10:06 ET | 13127 | 131.43 |
| 10:08 ET | 7625 | 131.355 |
| 10:10 ET | 10906 | 131.46 |
| 10:12 ET | 17632 | 131.5 |
| 10:14 ET | 25923 | 131.51 |
| 10:15 ET | 19578 | 131.64 |
| 10:17 ET | 26910 | 131.57 |
| 10:19 ET | 10478 | 131.56 |
| 10:21 ET | 22698 | 131.44 |
| 10:24 ET | 3970 | 131.53 |
| 10:26 ET | 6875 | 131.65 |
| 10:28 ET | 7332 | 131.53 |
| 10:30 ET | 6999 | 131.525 |
| 10:32 ET | 6078 | 131.48 |
| 10:33 ET | 10115 | 131.49 |
| 10:35 ET | 12039 | 131.555 |
| 10:37 ET | 8956 | 131.65 |
| 10:39 ET | 16834 | 131.78 |
| 10:42 ET | 9905 | 131.87 |
| 10:44 ET | 9939 | 131.83 |
| 10:46 ET | 12426 | 131.87 |
| 10:48 ET | 6239 | 131.72 |
| 10:50 ET | 5270 | 131.7267 |
| 10:51 ET | 3948 | 131.6504 |
| 10:53 ET | 5620 | 131.7 |
| 10:55 ET | 7142 | 131.71 |
| 10:57 ET | 6880 | 131.679 |
| 11:00 ET | 10639 | 131.66 |
| 11:02 ET | 28356 | 131.71 |
| 11:04 ET | 12546 | 131.73 |
| 11:06 ET | 9063 | 131.57 |
| 11:08 ET | 11709 | 131.63 |
| 11:09 ET | 18352 | 131.67 |
| 11:11 ET | 9315 | 131.5 |
| 11:13 ET | 12893 | 131.48 |
| 11:15 ET | 4322 | 131.43 |
| 11:18 ET | 5510 | 131.36 |
| 11:20 ET | 6702 | 131.33 |
| 11:22 ET | 42637 | 131.234 |
| 11:24 ET | 8639 | 131.1 |
| 11:26 ET | 14839 | 131.105 |
| 11:27 ET | 8100 | 131.1 |
| 11:29 ET | 69119 | 131.04 |
| 11:31 ET | 10326 | 131.14 |
| 11:33 ET | 7664 | 131.125 |
| 11:36 ET | 3973 | 131.08 |
| 11:38 ET | 10977 | 131.115 |
| 11:40 ET | 11852 | 131.1979 |
| 11:42 ET | 5238 | 131.1373 |
| 11:44 ET | 3334 | 131.12 |
| 11:45 ET | 5670 | 131.17 |
| 11:47 ET | 4350 | 131.16 |
| 11:49 ET | 9060 | 131.23 |
| 11:51 ET | 18927 | 131.21 |
| 11:54 ET | 3418 | 131.2801 |
| 11:56 ET | 3462 | 131.32 |
| 11:58 ET | 4333 | 131.29 |
| 12:00 ET | 4292 | 131.27 |
| 12:02 ET | 5596 | 131.28 |
| 12:03 ET | 1773 | 131.2919 |
| 12:05 ET | 4324 | 131.27 |
| 12:07 ET | 6089 | 131.29 |
| 12:09 ET | 5217 | 131.299 |
| 12:12 ET | 4585 | 131.25 |
| 12:14 ET | 8422 | 131.22 |
| 12:16 ET | 21774 | 131.24 |
| 12:18 ET | 11371 | 131.16 |
| 12:20 ET | 5525 | 131.29 |
| 12:21 ET | 3352 | 131.28 |
| 12:23 ET | 4148 | 131.285 |
| 12:25 ET | 4668 | 131.3 |
| 12:27 ET | 3052 | 131.26 |
| 12:30 ET | 2279 | 131.3 |
| 12:32 ET | 4328 | 131.2701 |
| 12:34 ET | 6223 | 131.3899 |
| 12:36 ET | 7515 | 131.4396 |
| 12:38 ET | 9561 | 131.465 |
| 12:39 ET | 4166 | 131.44 |
| 12:41 ET | 3929 | 131.32 |
| 12:43 ET | 2441 | 131.34 |
| 12:45 ET | 4511 | 131.3 |
| 12:48 ET | 8953 | 131.23 |
| 12:50 ET | 17706 | 131.2 |
| 12:52 ET | 3429 | 131.175 |
| 12:54 ET | 6118 | 131.1133 |
| 12:56 ET | 10781 | 131.07 |
| 12:57 ET | 8939 | 131.1 |
| 12:59 ET | 7486 | 131.1 |
| 01:01 ET | 5331 | 131.16 |
| 01:03 ET | 14356 | 131.165 |
| 01:06 ET | 4790 | 131.17 |
| 01:08 ET | 3779 | 131.09 |
| 01:10 ET | 8855 | 131.15 |
| 01:12 ET | 3943 | 131.1801 |
| 01:14 ET | 4846 | 131.3 |
| 01:15 ET | 11605 | 131.32 |
| 01:17 ET | 4599 | 131.34 |
| 01:19 ET | 5496 | 131.215 |
| 01:21 ET | 10376 | 131.185 |
| 01:24 ET | 5409 | 131.165 |
| 01:26 ET | 8918 | 131.205 |
| 01:28 ET | 7806 | 131.15 |
| 01:30 ET | 19631 | 131.2 |
| 01:32 ET | 6927 | 131.16 |
| 01:33 ET | 9071 | 131.17 |
| 01:35 ET | 12004 | 131.11 |
| 01:37 ET | 4598 | 131.03 |
| 01:39 ET | 12265 | 131.03 |
| 01:42 ET | 6173 | 131.15 |
| 01:44 ET | 13013 | 131.07 |
| 01:46 ET | 16554 | 131.075 |
| 01:48 ET | 9413 | 131.09 |
| 01:50 ET | 5710 | 131.075 |
| 01:51 ET | 7758 | 131.07 |
| 01:53 ET | 5225 | 131.01 |
| 01:55 ET | 5258 | 130.98 |
| 01:57 ET | 9544 | 130.98 |
| 02:00 ET | 10967 | 130.95 |
| 02:02 ET | 8756 | 130.96 |
| 02:04 ET | 6465 | 130.93 |
| 02:06 ET | 9089 | 130.93 |
| 02:08 ET | 6059 | 130.95 |
| 02:09 ET | 11321 | 131 |
| 02:11 ET | 9384 | 131.01 |
| 02:13 ET | 5242 | 131.058 |
| 02:15 ET | 5835 | 131.05 |
| 02:18 ET | 6664 | 130.97 |
| 02:20 ET | 6172 | 130.86 |
| 02:22 ET | 14674 | 130.86 |
| 02:24 ET | 7253 | 130.87 |
| 02:26 ET | 5908 | 130.87 |
| 02:27 ET | 7357 | 130.895 |
| 02:29 ET | 4142 | 130.87 |
| 02:31 ET | 9832 | 130.885 |
| 02:33 ET | 6098 | 130.92 |
| 02:36 ET | 11473 | 130.87 |
| 02:38 ET | 7658 | 130.98 |
| 02:40 ET | 10594 | 130.96 |
| 02:42 ET | 18195 | 130.975 |
| 02:44 ET | 6433 | 130.92 |
| 02:45 ET | 6389 | 130.95 |
| 02:47 ET | 8597 | 130.905 |
| 02:49 ET | 6319 | 130.855 |
| 02:51 ET | 8089 | 130.82 |
| 02:54 ET | 7226 | 130.775 |
| 02:56 ET | 13961 | 130.81 |
| 02:58 ET | 21861 | 130.8825 |
| 03:00 ET | 14587 | 130.85 |
| 03:02 ET | 13530 | 130.92 |
| 03:03 ET | 20324 | 130.87 |
| 03:05 ET | 8738 | 130.875 |
| 03:07 ET | 7949 | 130.85 |
| 03:09 ET | 6385 | 130.905 |
| 03:12 ET | 9089 | 130.915 |
| 03:14 ET | 7072 | 130.93 |
| 03:16 ET | 14760 | 130.97 |
| 03:18 ET | 14293 | 131 |
| 03:20 ET | 8652 | 131 |
| 03:21 ET | 10159 | 131.09 |
| 03:23 ET | 7813 | 131.11 |
| 03:25 ET | 7015 | 131.07 |
| 03:27 ET | 10879 | 131.11 |
| 03:30 ET | 13852 | 131.085 |
| 03:32 ET | 8866 | 131.06 |
| 03:34 ET | 11058 | 131.04 |
| 03:36 ET | 11438 | 130.96 |
| 03:38 ET | 12808 | 130.965 |
| 03:39 ET | 14812 | 130.925 |
| 03:41 ET | 25331 | 130.88 |
| 03:43 ET | 14563 | 130.925 |
| 03:45 ET | 20989 | 130.91 |
| 03:48 ET | 21557 | 130.91 |
| 03:50 ET | 19462 | 130.98 |
| 03:52 ET | 43671 | 130.9 |
| 03:54 ET | 32226 | 131.01 |
| 03:56 ET | 74715 | 131.085 |
| 03:57 ET | 79047 | 131.145 |
| 03:59 ET | 157626 | 131.09 |
May 15, 2024
May 13, 2024
DJ Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study, from 7:45AM ET on Monday May 13, 2024 by Dow Jones
7:45AM ET on Monday May 13, 2024 by Dow JonesMerck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma, from 6:45AM ET on Monday May 13, 2024 by Dow Jones
6:45AM ET on Monday May 13, 2024 by Dow Jones
May 10, 2024
DJ A Struggling Pfizer Looks for Help From a Wall Streeter -- Barrons.com, from 8:02PM ET on Friday May 10, 2024 by Dow Jones
8:02PM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
DJ Merck Study of Keytruda With Chemotherapy in Endometrial Cancer Fails to Meet Endpoint, from 8:00AM ET on Thursday May 09, 2024 by Dow Jones
8:00AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Merck & Co Inc | 332.1B | 146.9x | -43.23% |
AbbVie Inc | 281.9B | 47.1x | -6.05% |
Roche Holding AG | 208.7B | 16.3x | +3.28% |
AstraZeneca PLC | 243.5B | 38.6x | +17.52% |
Pfizer Inc | 167.7B | -472.0x | -7.10% |
Johnson & Johnson | 369.4B | 22.0x | -1.47% |
Company Information
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. It sells these human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand.
Contact Information
- Headquarters
- 126 East Lincoln AvenueRAHWAY, NJ, United States 07065
- Phone
- 908-740-4000
- Fax
- 908-423-1987
Executives
- Chairman of the Board, President, Chief Executive Officer
- Robert Davis
- Chief Financial Officer, Executive Vice President
- Caroline Litchfield
- Chief People Officer
- Betty Larson
- Executive Vice President, Chief Information and Digital Officer
- David Williams
- Executive Vice President, General Counsel, Corporate Secretary
- Jennifer Zachary
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $332.1B |
|---|---|
Revenue (TTM) | $61.4B |
Shares Outstanding | 2.5B |
Dividend Yield | 2.35% |
Annual Dividend Rate | 3.0800 USD |
Ex-Dividend Date | 03-14-24 |
Pay Date | 04-05-24 |
Beta | 0.41 |
EPS | $0.89 |
Book Value | $14.84 |
P/E Ratio | 146.9x |
Price/Sales (TTM) | 5.4 |
Price/Cash Flow (TTM) | 53.7x |
Operating Margin | 5.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
